Pancreatic Cancer – Pipeline Review, H2 2016’, provides an overview of the Pancreatic Cancer pipeline landscape- ken Research Global Markets Direct’s, ‘Pancreatic Cancer – Pipeline Review, H2 2016’, provides an overview of the Pancreatic Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also… Read More »
